Literature DB >> 12652349

Essential conservation of D1 mutant phenotype at the level of individual topographies of behaviour in mice lacking both D1 and D3 dopamine receptors.

John Y F Wong1, Jeremiah J Clifford, Jim S Massalas, Anthony Kinsella, John L Waddington, John Drago.   

Abstract

RATIONALE: In the absence of agonists and antagonists evidencing appropriate selectivities, individual and interactive properties of D(1) and D(3) dopamine receptors would be illuminated most powerfully by their co-deletion.
OBJECTIVES: To define and contrast the behavioural phenotype of D(1)/D(3) double knockout mice in comparison with wild types, and with individual D(1) and D(3 )mutants.
METHODS: Behavioural phenotype was characterised using an ethologically based topographical technique.
RESULTS: On comparison with wild types, D(1)/D(3) double mutants were characterised topographically as follows: increases in sniffing and locomotion, which evidenced delayed habituation; reductions in rearing free, rearing seated, grooming, chewing and stillness. Though the D(1)/D(3) double mutant ethogram comprised elements of both single mutant D(1) and D(3) lines, this phenotype was largely reflective of the D(1) mutant component.
CONCLUSIONS: Distinct patterns of initial exploratory behaviour and of temporal change over subsequent habituation were evident across the three genotypes, with particular conservation of the D(1) phenotype in D(1)/D(3 )double mutants. Under the present conditions, there was little systematic evidence for D(1):D(3) interactions in the regulation of these aspects of behaviour.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12652349     DOI: 10.1007/s00213-003-1415-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  Late direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons.

Authors:  J Y Wong; P Padungchaichot; J S Massalas; J Drago
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 2.  New insights into dopaminergic receptor function using antisense and genetically altered animals.

Authors:  D R Sibley
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

Review 3.  Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms.

Authors:  J L Waddington
Journal:  Int Rev Neurobiol       Date:  1989       Impact factor: 3.230

4.  Phenotypic resolution of spontaneous and D1-like agonist-induced orofacial movement topographies in congenic dopamine D1A receptor 'knockout' mice.

Authors:  K Tomiyama; F N McNamara; J J Clifford; A Kinsella; J Drago; O Tighe; D T Croke; N Koshikawa; J L Waddington
Journal:  Neuropharmacology       Date:  2002-04       Impact factor: 5.250

5.  D3 dopamine receptor-deficient mouse: evidence for reduced anxiety.

Authors:  H Steiner; S Fuchs; D Accili
Journal:  Physiol Behav       Date:  1997-12-31

6.  Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.

Authors:  M Xu; T E Koeltzow; G T Santiago; R Moratalla; D C Cooper; X T Hu; N M White; A M Graybiel; F J White; S Tonegawa
Journal:  Neuron       Date:  1997-10       Impact factor: 17.173

7.  PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.

Authors:  N Ginovart; A Lundin; L Farde; C Halldin; L Bäckman; C G Swahn; S Pauli; G Sedvall
Journal:  Brain       Date:  1997-03       Impact factor: 13.501

Review 8.  Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome.

Authors:  B S Peterson
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

Review 9.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

Review 10.  Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants.

Authors:  J Drago; P Padungchaichot; D Accili; S Fuchs
Journal:  Dev Neurosci       Date:  1998       Impact factor: 2.984

View more
  4 in total

Review 1.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

2.  Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disorders.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2017-07-20       Impact factor: 2.643

3.  Psychomotor stimulant effects of cocaine in rats and 15 mouse strains.

Authors:  Morgane Thomsen; S Barak Caine
Journal:  Exp Clin Psychopharmacol       Date:  2011-10       Impact factor: 3.157

4.  Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice.

Authors:  Sarah Jane Harrison; José N Nobrega
Journal:  Psychopharmacology (Berl)       Date:  2008-12-19       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.